Terms: = Head and neck cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Clinical Outcome
4 results:
1. Downregulation of CCL22 and mutated notch1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
Li X; Liu Z; Zhou W; Liu X; Cao W
BMC Cancer; 2021 Aug; 21(1):922. PubMed ID: 34391381
[TBL] [Abstract] [Full Text] [Related]
2. Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma.
de Carvalho AC; Perdomo S; Dos Santos W; Fernandes GC; de Jesus LM; Carvalho RS; Scapulatempo-Neto C; de Almeida GC; Sorroche BP; Arantes LMRB; Melendez ME; De Marchi P; Hayes N; Reis RM; Carvalho AL
Sci Rep; 2020 Jun; 10(1):9970. PubMed ID: 32561788
[TBL] [Abstract] [Full Text] [Related]
3. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.
Ma J; Fu Y; Tu YY; Liu Y; Tan YR; Ju WT; Pickering CR; Myers JN; Zhang ZY; Zhong LP
BMC Cancer; 2018 Jul; 18(1):758. PubMed ID: 30041611
[TBL] [Abstract] [Full Text] [Related]
4. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract] [Full Text] [Related]
